Inventor · disambiguated record
Grahame Woollam
Also filed as: WOOLLAM GRAHAME · WOOLLAM GRAHAME ROBERT
12 granted patents·4 pending applications·84 citations·filing 2007–2024
92Inventor score
Files withTHERAVANCE BIOPHARMA R&D IP LLC8WOOLLAM GRAHAME4GLAXO GROUP LTD2BIGGADIKE KEITH1NOVARTIS AG1
Top patents by PatentIndex Score
16 records- 0195US11008289B2Crystalline freebase forms of a biphenyl compoundTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted May 18, 2021·5 cites·9 claims
- 0293US9765028B2Crystalline freebase forms of a biphenyl compoundTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2016·Granted Sep 19, 2017·8 cites·6 claims
- 0393US9226896B2Crystalline freebase forms of a biphenyl compoundWOOLLAM GRAHAME·Filed 2014·Granted Jan 5, 2016·16 cites·17 claims
- 0493US8921396B2Crystalline freebase forms of a biphenyl compoundWOOLLAM GRAHAME·Filed 2013·Granted Dec 30, 2014·16 cites·12 claims
- 0593US8541451B2Crystalline freebase forms of a biphenyl compoundWOOLLAM GRAHAME·Filed 2010·Granted Sep 24, 2013·17 cites·17 claims
- 0692US10550081B2Crystalline freebase forms of a biphenyl compoundTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2018·Granted Feb 4, 2020·6 cites·4 claims
- 0792US9415041B2Crystalline freebase forms of a biphenyl compoundWOOLLAM GRAHAME·Filed 2015·Granted Aug 16, 2016·8 cites·12 claims
- 0891US10100013B2Crystalline freebase forms of a biphenyl compoundTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2017·Granted Oct 16, 2018·6 cites·9 claims
- 0990US2025179019A1Crystalline freebase forms of a biphenyl compoundTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2024·Application pending·0 cites
- 1087US11858898B2Crystalline freebase forms of a biphenyl compoundTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2023·Granted Jan 2, 2024·0 cites·27 claims
- 1183US11649209B2Crystalline freebase forms of a biphenyl compoundTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2022·Granted May 16, 2023·0 cites·11 claims
- 1277US11691948B2Crystalline freebase forms of a biphenyl compoundTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2021·Granted Jul 4, 2023·0 cites·21 claims
- 1376US8178573B2CompoundsBIGGADIKE KEITH·Filed 2007·Granted May 15, 2012·2 cites·12 claims
- 1444US2010317672A1Monomaleate Monohydrate Salt of a 5HT1A Receptor AntagonistGLAXO GROUP LTD·Filed 2009·Application pending·0 cites
- 1544US2011034524A1Hemi-fumarate salt of a 1,3,4-thiadiazolyl derivative as modulator of the sphingosine 1-phosphate receptorGLAXO GROUP LTD·Filed 2009·Application pending·0 cites
- 1642US2020289514A1Novel Pyrazolo Pyrimidine DerivativesNOVARTIS AG·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →